Cellectis S.A. - American Depositary Shares — Dividend History & Yield (NASDAQ:CLLS) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

Cellectis S.A. - American Depositary Shares

Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.

Notizie

Jefferies avvia copertura su Cellectis con rating Buy

Jefferies assumes coverage on Cellectis stock with Buy rating

This Levi Strauss Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Brunswick (NYSE:BC), Cellectis (NASDAQ:CLLS)

Clear Street inizia la copertura di Cellectis con rating Buy sul potenziale CAR-T

Clear Street initiates Cellectis stock with Buy rating on CAR-T potential

Cellectis: Showcasing Encouraging Data, But Still Early To Make A Run Like This (CLLS)

Allogene Arbitration Victory Pressures Cellectis Shares Tuesday - Allogene Therapeutics (NASDAQ:ALLO), Cellectis (NASDAQ:CLLS)

Lightwave Logic, Kyverna Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Argo Blockchain (NASDAQ:ARBK), Ascent Solar Technologies (NASDAQ:ASTI)

Azioni Allogene in rialzo dopo sentenza arbitrale favorevole sui diritti terapeutici

Sentenza arbitrale riafferma il controllo di Allogene sulla terapia anticancro

Allogene stock rises after favorable arbitration ruling reaffirms therapy rights

Decisione arbitrale termina parzialmente l’accordo di licenza tra Cellectis e Servier